Who is sponsoring AWARD?

AWARD is sponsored by Pulsar Vascular.

Last reviewed 2019-02-07 · How we verify

Safety Study of the PulseRider® in Patients Undergoing Treatment for Bifurcation Intracranial Aneurysms (AWARD)

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

NCT02435823 NA COMPLETED

This is a prospective multi-center, single arm, non-randomized study. It is designed to evaluate the safety of the PulseRider® in patients undergoing treatment for bifurcation intracranial aneurysms.

Details

Lead sponsor	Pulsar Vascular
Phase	NA
Status	COMPLETED
Enrolment	35
Start date	Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Dec 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Brain Aneurysm

Interventions

PulseRider

Countries

Austria